Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Tuesday, 10 October 2017

Hofseth Biocare ASA: Financial Update

Hofseth Biocare ASA    

Published: 10:17 CEST 10-10-2017 /GlobeNewswire /Source: Hofseth Biocare ASA / : HBC /ISIN: NO0010598683

Hofseth Biocare ASA: Financial Update

Based on preliminary figures for the Third Quarter 2017, Hofseth BioCare ASA (HBC) management expects to report group revenues of approximately NOK 28m for the quarter, compared to NOK 3.6m in the same quarter 2016.
 
The cash balance by the end of Q3 was approx. NOK 30m. HBC will report 3rd quarter 2017 financial results 15th November 2017.
 
For further information, please contact:
Roger Hofseth, CEO of Hofseth BioCare ASA
Mob: +47 95147941
E-mail: rh@hofseth-as.no
 
Jon Olav Ødegård, CFO of Hofseth BioCare ASA
Mob: +47 93632966
E-mail: joo@hofsethbiocare.no
 
About Hofseth BioCare ASA:
HBC is a Norwegian biotech company that offers high-value ingredients and finished products for humans and pets. The company is founded on the core values of sustainability, traceability and optimal utilization of natural resources. Through an innovative hydrolysis technology, HBC is able to preserve the quality of salmon oil, proteins and calcium, prepared of fresh salmon off-cuts. HBC's objective is to contribute to the efficient use of marine resources and deliver quality products for ingredients and finished consumer products in the nutrition market.
Hofseth BioCare's headquarters are located in Ålesund, Norway with branches in Oslo, Chicago, Mumbai and Tokyo. HBC is listed on Oslo Stock Exchange Axess list with ticker "HBC". More information about Hofseth BioCare at www.hofsethbiocare.com and www.facebook.com/hofsethbiocare
 
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.




This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of Nasdaq Corporate Solutions clients. Source: Hofseth Biocare ASA, Molovegen 6, Ålesund 6004, Norway
If you would like to unsubscribe and stop receiving these e-mails click here.